Last reviewed · How we verify

NCT06140784

A Clinical Study to Assess the Gingivitis and Plaque Effects of Various Dentifrices

Completed NA Last updated 1 March 2024
What this trial tests

NA trial testing 0.76% Sodium Monofluorophosphate Dentifrice in Gingivitis in 116 participants. Completed in 10 December 2023.

Timeline
2 September 2023
Primary endpoint
10 December 2023
10 December 2023

Quick facts

Lead sponsorProcter and Gamble
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment116
Start date2 September 2023
Primary completion10 December 2023
Estimated completion10 December 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Procter and Gamble — full company profile →

Who can join

18 and older, any sex, with Gingivitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study is to evaluate the effect four different dentifrices have on gingivitis after 12 weeks of product use. The secondary objectives are to assess the effect four dentifrices, have on plaque and oral microbiome composition.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of 0.76% Sodium Monofluorophosphate Dentifrice

Trials testing the same drug.

Other recruiting trials for Gingivitis

Currently open trials in the same condition.

Other Procter and Gamble trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06140784.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing